INNOSPEC INC. (IOSP)
Chemicals & Allied Products · Healthcare · $2.1B
Intrinsic Value (Consensus)
$108.50
Current Price
$83.74
Margin of Safety
+29.6%
29.6% Below Intrinsic Value
Value: $109
Price: $84
Valuation Model Estimates
Current Price: $83.74
DCF (Discounted Cash Flow)
$220.57
Graham Number
$74.67
Earnings Power Value
$45.34
Relative Value (P/E)
$93.40
Dividend Discount Model
$296.67
Consensus Value
$108.50
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
61
Profitability
15/25
Strength
17/25
Valuation
19/25
Growth
10/25
Financial Health Signals
Declining revenue — top line is shrinking
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $4.67
- EPS (Forward)
- $5.60
- Book Value
- $53.06
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 9.0%
- Debt/Equity
- —
- Revenue Growth
- -3.7%
- Earnings Growth
- 20.0%
- Dividend Yield
- 1.0%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance